EOLS
Evolus, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.52
−1.51%Leverage
- Debt / equity
- -5.33x
- Net debt / equity
- -3.87x
- Debt / assets
- 0.66x
- Debt / EBITDA
- -22.85x
- Net debt / EBITDA
- -16.59x
Liquidity & coverage
- Current ratio
- 1.70x
- Quick ratio
- 1.28x
- Cash ratio
- 0.46x
- Interest coverage
- -1.43x
- EBITDA / interest
- -0.44x
- Working capital
- $68.8M
Cash & dividend
- FCF / debt
- -0.12x
- Cash flow / debt
- -0.09x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026